Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine and atorvastatin for prevention of perioperative myocardial injury after urgent hip fracture surgery
ACTRN12612000340831Phase 4Not yet recruiting
- Sponsor
- Northern Health
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ivabradine and atorvastatin in Myocardial injury and coronary arteriosclerosis, sponsored by Northern Health. Primary endpoint: Frequency and magnitude of new myocardial injury at Day 3. Planned start Apr 2012; status: not yet recruiting.
02
Drugs
ivabradineatorvastatin
03
Conditions
Myocardial injurycoronary arteriosclerosis
Beyond the preview
Go deeper on ACTRN12612000340831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000340831.